Found 13 matching trials
Efficacy of Fixed Combination of Beclomethasone Dipropionate (BDP) + Formoterol Fumarate (FF) + Glycopyrronium Bromide (GB) (CHF 5993)Administered Via Dry Powder Inhaler (DPI) in Chronic Obstructive Pulmonary Disease (COPD) PHASE2 The purpose of this study is to evaluate the efficacy of Fixed Combination ...
Show More Location
Medical Center Convex EOOD
Learn More & Join Trial
A Phase II, 5-way Cross-over Study to Evaluate the Pharmacodynamics of "Nexthaler" Dry Powder Inhaler in COPD Patients PHASE2 The study aim is to compare the pharmacodynamic effects (cardiovascular eff...
Show More Location
Medicine Evaluation Unit
Learn More & Join Trial
VENTURI (VENTilation Using Respiratory Imaging) PHASE2 The purpose of the study is to enroll participants with uncontrolled asthma...
Show More Location
The University of Alabama at Birmingham
Learn More & Join Trial
A Study Comparing the Efficacy and Safety of CHF 1535 (BDP +FF) Inhalation Powder, Administered Via the NEXT Inhaler, Versus CHF 1535 (BDP +FF), Administered Via a pMDI, in Moderate to Severe Asthma PHASE3 To demonstrate that CHF 1535 via NEXT DPI (beclomethasone dipropionate + fo...
Show More Location
Oliver Kornmann - National Coordinator in Germany
Learn More & Join Trial
Functional Respiratory Imaging Study (DARWiIN) PHASE3 The objective of this clinical study was to evaluate the tolerability, safe...
Show More Location
OLV Hospital Aalst
Learn More & Join Trial
Lung Deposition of the BDP/Formoterol Combination Administered Via the NEXT DPI in Healthy, Asthmatic and COPD Patients PHASE1 The purpose of this study is to investigate the lung deposition and distrib...
Show More Location
Inamed Research GmbH & Co. KG
Learn More & Join Trial
Foster 100/6 mg NEXThaler Versus Foster 100/6mg Pressurized Metered-dose Inhaler (pMDI) in Patients With Controlled Asthma. PHASE3 Primary Objective
To demonstrate the non-inferiority of Foster® NEXThaler®...
Show More Location
Chiesi Clinical Trial site 15641
Learn More & Join Trial
Clinical Pharmacology of 35/4 NEXThaler® in Children 5-11 Years Old PHASE2 The study will be conducted in asthmatic children aged 5 to 11 years and is...
Show More Location
BørneAstmaKlinikken, Hans Knudsens Plads 1A,
Learn More & Join Trial
A Study Comparing the Pharmacokinetic, Pharmacodynamic and Safety of CHF 1535 (Fixed Combination of Beclomethasone + Formoterol) Administered Via the NEXT DPI, Versus the Free Combination of Licenced Beclomethasone DPI and Formoterol DPI in Asthmatic Adolescent and Adult Patients. PHASE2 The purpose of this study is to demonstrate that the CHF 1535 (fixed combin...
Show More Location
Copenhagen University Hospital
Learn More & Join Trial
Study to Assess the Effect of the NEXThaler® Device (DPI - Dry Powder Inhaler) on the Central and Peripheral Airway Dimensions in Asthmatic Patients PHASE2 The objective of this study is to evaluate the effect of the combination of...
Show More Location
University Hospital of Antwerp
Learn More & Join Trial